Concepedia

Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with Armolipid Plus

Massimiliano Ruscica, Monica Gomaraschi, Giuliana Mombelli, Chiara Macchi, Raffaella Bosisio, Franco Pazzucconi, Chiara Pavanello, Laura Calabresi, Anna Arnoldi, Cesare R. Sirtori,

Journal of clinical lipidology · 2013 · 82 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Harmonizing the Metabolic Syndrome

K. G. M. M. Alberti, Robert H. Eckel, Scott M. Grundy et al. · Circulation · 2009 · 14.7K citations · Full text

, , +15

Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men

Tobias Pischon · JAMA · 2004 · 1.8K citations · Full text

, , +9

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Weijia Kong, Jing Wei, Parveen Abidi et al. · Nature Medicine · 2004 · 1.4K citations

, , +4

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine

Jean‐Marie Brusq, Nicolas Ancellin, Pascal Grondin et al. · Journal of Lipid Research · 2006 · 341 citations · Full text

, , +17

Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction

Zongliang Lu, Wen‐Rong Kou, Bao‐min Du et al. · The American Journal of Cardiology · 2008 · 315 citations

, , +14